ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells

R. L. McElveen, T. F. Lou, K. Reese, S. Xia, B. S. Baliga, Betty Sue Pace

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Fetal hemoglobin (HbF) induction is an effective approach to improve clinical symptoms in sickle cell disease. Understanding molecular mechanisms for gamma-gene re-activation will aid efforts to design lead compounds. A potential inhibitory role for the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway in gamma-gene expression has been suggested recently. Therefore, we determined the ability of U0126, a selective inhibitor of MEK1/2 the upstream activators of ERK, to re-activate gamma-globin expression. K562 stable lines over-expressing constitutively active MEK1 were established. A significant increase in ERK phosphorylation was observed and gamma-gene expression was silenced concomitantly, however U0126 attenuated this effect. Studies in human erythroid progenitors confirmed the ability of U0126 to induce HbF. Cellular mechanisms for the inhibitory role of ERK signaling in drug-mediated HbF induction will be discussed.

Original languageEnglish (US)
Pages (from-to)215-227
Number of pages13
JournalCellular and Molecular Biology
Volume51
Issue number2
StatePublished - Sep 5 2005
Externally publishedYes

Fingerprint

gamma-Globins
Erythroid Cells
Extracellular Signal-Regulated MAP Kinases
Gene expression
Lead compounds
Gene Expression
Fetal Hemoglobin
Phosphorylation
Sickle Cell Anemia
Mitogen-Activated Protein Kinases
Transcriptional Activation
Genes
Chemical activation
U 0126
Pharmaceutical Preparations

Keywords

  • ERK
  • Fetal hemoglobin
  • Gamma-globin
  • Sickle cell disease
  • U0126

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

McElveen, R. L., Lou, T. F., Reese, K., Xia, S., Baliga, B. S., & Pace, B. S. (2005). ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells. Cellular and Molecular Biology, 51(2), 215-227.

ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells. / McElveen, R. L.; Lou, T. F.; Reese, K.; Xia, S.; Baliga, B. S.; Pace, Betty Sue.

In: Cellular and Molecular Biology, Vol. 51, No. 2, 05.09.2005, p. 215-227.

Research output: Contribution to journalArticle

McElveen, RL, Lou, TF, Reese, K, Xia, S, Baliga, BS & Pace, BS 2005, 'ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells', Cellular and Molecular Biology, vol. 51, no. 2, pp. 215-227.
McElveen, R. L. ; Lou, T. F. ; Reese, K. ; Xia, S. ; Baliga, B. S. ; Pace, Betty Sue. / ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells. In: Cellular and Molecular Biology. 2005 ; Vol. 51, No. 2. pp. 215-227.
@article{5841cf012d4044cab22f964d3e94cb57,
title = "ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells",
abstract = "Fetal hemoglobin (HbF) induction is an effective approach to improve clinical symptoms in sickle cell disease. Understanding molecular mechanisms for gamma-gene re-activation will aid efforts to design lead compounds. A potential inhibitory role for the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway in gamma-gene expression has been suggested recently. Therefore, we determined the ability of U0126, a selective inhibitor of MEK1/2 the upstream activators of ERK, to re-activate gamma-globin expression. K562 stable lines over-expressing constitutively active MEK1 were established. A significant increase in ERK phosphorylation was observed and gamma-gene expression was silenced concomitantly, however U0126 attenuated this effect. Studies in human erythroid progenitors confirmed the ability of U0126 to induce HbF. Cellular mechanisms for the inhibitory role of ERK signaling in drug-mediated HbF induction will be discussed.",
keywords = "ERK, Fetal hemoglobin, Gamma-globin, Sickle cell disease, U0126",
author = "McElveen, {R. L.} and Lou, {T. F.} and K. Reese and S. Xia and Baliga, {B. S.} and Pace, {Betty Sue}",
year = "2005",
month = "9",
day = "5",
language = "English (US)",
volume = "51",
pages = "215--227",
journal = "Cellular and Molecular Biology",
issn = "0145-5680",
publisher = "Cellular and Molecular Biology Association",
number = "2",

}

TY - JOUR

T1 - ERK pathway inhibitor U0126 induces gamma-globin expression in erythroid cells

AU - McElveen, R. L.

AU - Lou, T. F.

AU - Reese, K.

AU - Xia, S.

AU - Baliga, B. S.

AU - Pace, Betty Sue

PY - 2005/9/5

Y1 - 2005/9/5

N2 - Fetal hemoglobin (HbF) induction is an effective approach to improve clinical symptoms in sickle cell disease. Understanding molecular mechanisms for gamma-gene re-activation will aid efforts to design lead compounds. A potential inhibitory role for the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway in gamma-gene expression has been suggested recently. Therefore, we determined the ability of U0126, a selective inhibitor of MEK1/2 the upstream activators of ERK, to re-activate gamma-globin expression. K562 stable lines over-expressing constitutively active MEK1 were established. A significant increase in ERK phosphorylation was observed and gamma-gene expression was silenced concomitantly, however U0126 attenuated this effect. Studies in human erythroid progenitors confirmed the ability of U0126 to induce HbF. Cellular mechanisms for the inhibitory role of ERK signaling in drug-mediated HbF induction will be discussed.

AB - Fetal hemoglobin (HbF) induction is an effective approach to improve clinical symptoms in sickle cell disease. Understanding molecular mechanisms for gamma-gene re-activation will aid efforts to design lead compounds. A potential inhibitory role for the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway in gamma-gene expression has been suggested recently. Therefore, we determined the ability of U0126, a selective inhibitor of MEK1/2 the upstream activators of ERK, to re-activate gamma-globin expression. K562 stable lines over-expressing constitutively active MEK1 were established. A significant increase in ERK phosphorylation was observed and gamma-gene expression was silenced concomitantly, however U0126 attenuated this effect. Studies in human erythroid progenitors confirmed the ability of U0126 to induce HbF. Cellular mechanisms for the inhibitory role of ERK signaling in drug-mediated HbF induction will be discussed.

KW - ERK

KW - Fetal hemoglobin

KW - Gamma-globin

KW - Sickle cell disease

KW - U0126

UR - http://www.scopus.com/inward/record.url?scp=30644469601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30644469601&partnerID=8YFLogxK

M3 - Article

C2 - 16171557

AN - SCOPUS:30644469601

VL - 51

SP - 215

EP - 227

JO - Cellular and Molecular Biology

JF - Cellular and Molecular Biology

SN - 0145-5680

IS - 2

ER -